| 000 | 01769 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515194236.0 | ||
| 264 | 0 | _c20100420 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2009.11.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Ya-juan | |
| 245 | 0 | 0 |
_aZl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cFeb 2010 |
||
| 300 |
_a252-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemistry |
| 650 | 0 | 4 |
_aCyclic Nucleotide Phosphodiesterases, Type 4 _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFurans _xchemistry |
| 650 | 0 | 4 |
_aLipopolysaccharides _ximmunology |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _ximmunology |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPeroxidase _xdrug effects |
| 650 | 0 | 4 |
_aPhenyl Ethers _xchemistry |
| 650 | 0 | 4 | _aPhosphodiesterase 4 Inhibitors |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 700 | 1 | _aJiang, Ya-li | |
| 700 | 1 | _aTang, Hui-fang | |
| 700 | 1 | _aZhao, Chun-zhen | |
| 700 | 1 | _aChen, Ji-qiang | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 10 _gno. 2 _gp. 252-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2009.11.008 _zAvailable from publisher's website |
| 999 |
_c19300530 _d19300530 |
||